PLAUR and gastric cancer: For example, AH-6809 (a kind of EP 2 antagonist, ranked third among all drugs) could inhibit HP-induced uPA and uPAR mRNA expressions, which suppressed the process of degradation of the extracellular matrix, tumor invasion, and metastasis of GC [67].